Arcturus Therapeutics Holdings (ARCT) EBT Margin Growth (1y) (2019 - 2026)
Arcturus Therapeutics Holdings (ARCT) EBT Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -1,532.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1,558.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - | -135,583.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -135,583.00 |
| Dec 31, 2025 | -27,234.00 |
| Sep 30, 2025 | -6,132.00 |
| Jun 30, 2025 | 241.00 |
| Mar 31, 2025 | 2,167.00 |
| Dec 31, 2024 | -9,472.00 |
| Sep 30, 2024 | 1,687.00 |
| Jun 30, 2024 | 45,926.00 |
| Mar 31, 2024 | -13,293.00 |
| Dec 31, 2023 | -11,111.00 |
| Sep 30, 2023 | 22,983.00 |
| Jun 30, 2023 | -41,450.00 |
| Mar 31, 2023 | 103,911.00 |
| Dec 31, 2022 | 72,374.00 |
| Sep 30, 2022 | 194,470.00 |
| Jun 30, 2022 | 260,507.00 |
| Mar 31, 2022 | 173,538.00 |
| Dec 31, 2021 | 73,911.00 |
| Sep 30, 2021 | -131,102.00 |
| Jun 30, 2021 | -225,219.00 |